AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $257.3M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.10pm 30/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 62.5¢ | Day High | 64.5¢ | Day Low | 61.0¢ | |||
| Daily Volume | 880558 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 61.0¢ | 6584 | 0 | 61.5¢ | 8205 | |
Directors & Senior Management
| Mr. Chris Taylor | Non-Executive Director |
| Mr. David Cavanagh | Chief Financial Officer |
| Mr. Dennison Hambling | MD, CEO & Executive Deputy Chairman |
| Mr. Jason Biddell | Chief Strategy Officer |
| Mr. Mark Allen Brisson | Independent Non-Executive Director |
| Mr. Neil Green | Company Secretary & Chief Risk Officer |
| Mr. Peter David Kennan | Non-Executive Chairman |
| Mr. Robert Hilton | Non-Executive Director |
| Shenin Singh | Head of Business Intelligence |
Data source: ADVFN
